ResMed shares are trading higher. The stock saw volume after Apple announced sleep apnea features for its new Apple watch.
Portfolio Pulse from Benzinga Newsdesk
ResMed shares are trading higher following Apple's announcement of sleep apnea features for its new Apple Watch, which has increased trading volume for ResMed stock.
September 09, 2024 | 5:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ResMed shares are experiencing a rise in trading volume and price following Apple's announcement of sleep apnea features in its new Apple Watch.
The introduction of sleep apnea features in Apple's new Watch could increase awareness and demand for sleep apnea solutions, benefiting ResMed, a leader in this space. This has led to increased trading volume and a positive price movement for RMD.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80